PepGen (PEPG) Non Operating Income (2021 - 2026)

PepGen (PEPG) reported Non Operating Income of $1.2 million for Q1 2026, up 6.7% on a YoY basis from $1.1 million in Q1 2025, and down 15.56% sequentially from $1.4 million in Q4 2025.

PepGen (PEPG) Non Operating Income (2021 - 2026) Analysis & Trends

PepGen (PEPG) has 6 years of Non Operating Income data on file, last reported at $1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income rose 6.7% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (down 37.04% YoY), and the FY2025 full-year result was $4.0 million, down 43.9% from the prior year.
  • Non Operating Income retreated to $1.2 million in Q1 2026, from $1.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.1 million in Q2 2024 to a low of $67000.0 in Q1 2022.
  • A 5-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Non Operating Income.
  • Across the five-year window, Non Operating Income jumped 2885.29% in 2022 and sank 64.86% in 2025, its largest moves.
  • Tracing PEPG's Non Operating Income over 5 years: stood at $1.6 million in 2022, then declined by 11.13% to $1.4 million in 2023, then advanced by 6.98% to $1.5 million in 2024, then dropped by 4.85% to $1.4 million in 2025, then slipped by 15.56% to $1.2 million in 2026.
  • Business Quant data shows PEPG's Non Operating Income at $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $628000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 PepGen 145.09 Mn 145.09 Mn - 1.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.19 Mn
Dec 31, 2025 1.41 Mn
Sep 30, 2025 628,000.00
Jun 30, 2025 845,000.00
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.49 Mn
Sep 30, 2024 1.79 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 1.78 Mn
Dec 31, 2023 1.39 Mn
Sep 30, 2023 1.49 Mn
Jun 30, 2023 1.62 Mn
Mar 31, 2023 1.71 Mn
Dec 31, 2022 1.56 Mn
Sep 30, 2022 947,000.00
Jun 30, 2022 326,000.00
Mar 31, 2022 67,000.00
Dec 31, 2021 67,000.00
Sep 30, 2021 -34,000.00
Jun 30, 2021 -197,000.00